These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16495857)

  • 1. [Topical tazarotene for severe congenital ichthyosis].
    Barbarot S; Acher-Chenebaux A; Stalder JF
    Ann Dermatol Venereol; 2006 Jan; 133(1):66-7. PubMed ID: 16495857
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of topical tazarotene in the treatment of congenital ichthyoses.
    Hofmann B; Stege H; Ruzicka T; Lehmann P
    Br J Dermatol; 1999 Oct; 141(4):642-6. PubMed ID: 10583110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical tazarotene vs. coal tar in stable plaque psoriasis.
    Kumar U; Kaur I; Dogra S; De D; Kumar B
    Clin Exp Dermatol; 2010 Jul; 35(5):482-6. PubMed ID: 19874376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tazarotene for the treatment of ectropion in ichthyosis.
    Craiglow BG; Choate KA; Milstone LM
    JAMA Dermatol; 2013 May; 149(5):598-600. PubMed ID: 23677086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption.
    Nguyen V; Cunningham BB; Eichenfield LF; Alió AB; Buka RL
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S123-5. PubMed ID: 17938025
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of keratoderma blennorrhagicum with tazarotene gel 0.1%.
    Lewis A; Nigro M; Rosen T
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):400-2. PubMed ID: 10901734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type I lamellar ichthyosis improved by tazarotene 0.1% gel.
    Marulli GC; Campione E; Chimenti MS; Terrinoni A; Melino G; Bianchi L
    Clin Exp Dermatol; 2003 Jul; 28(4):391-3. PubMed ID: 12823301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ichthyosis bullosa of Siemens: response to topical tazarotene.
    Rajiv S; Rakhesh SV
    Indian J Dermatol Venereol Leprol; 2006; 72(1):43-6. PubMed ID: 16481710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KID syndrome.
    Abdollahi A; Hallaji Z; Esmaili N; Valikhani M; Barzegari M; Akhyani M; Toosi S; Miresmaili A
    Dermatol Online J; 2007 Oct; 13(4):11. PubMed ID: 18319008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Follicular dyskeratosis: successful treatment with local retinoid].
    Oster-Schmidt C; Stücker M; Altmeyer P
    Hautarzt; 2000 Mar; 51(3):196-9. PubMed ID: 10789083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
    Lebwohl MG; Breneman DL; Goffe BS; Grossman JR; Ling MR; Milbauer J; Pincus SH; Sibbald RG; Swinyer LJ; Weinstein GD; Lew-Kaya DA; Lue JC; Gibson JR; Sefton J
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):590-6. PubMed ID: 9777766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.
    Rigopoulos D; Gregoriou S; Katsambas A
    Acta Derm Venereol; 2007; 87(2):167-8. PubMed ID: 17340027
    [No Abstract]   [Full Text] [Related]  

  • 14. [Medication of the month. Tazarotene 0.05%-0.1% (Zorac)].
    Henno A; Hua MT; de la Brassinne M
    Rev Med Liege; 2003 Nov; 58(11):706-8. PubMed ID: 14748200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical application of tazarotene in the treatment of nonerythrodermic lamellar ichthyosis.
    Stege H; Hofmann B; Ruzicka T; Lehmann P
    Arch Dermatol; 1998 May; 134(5):640. PubMed ID: 9606345
    [No Abstract]   [Full Text] [Related]  

  • 16. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
    Poulin YP
    Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing treatment with topical tazarotene.
    Guenther LC
    Am J Clin Dermatol; 2003; 4(3):197-202. PubMed ID: 12627995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tazarotene 0.015% Cream as a Potential Topical Agent for Management of Ichthyosis in Dorfman-Chanarin Syndrome.
    Niculescu L; Ruini C; Srour J; Salzer S; Schönbuchner I; von Braunmühl T; Ruzicka T; Hohenleutner U; Giehl KA; Fischer J; Wollenberg A
    Acta Derm Venereol; 2019 Mar; 99(3):345-346. PubMed ID: 30460372
    [No Abstract]   [Full Text] [Related]  

  • 19. Schools of pharmacology: retinoid update.
    Scheinfeld N
    J Drugs Dermatol; 2006 Oct; 5(9):921-2. PubMed ID: 17039662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectropion Improvement with Topical Tazarotene in Children with Lamellar Ichthyosis.
    Hanson B; Becker L; Hook K; Polcari I; Areaux RG; Maguiness S
    Pediatr Dermatol; 2017 Sep; 34(5):584-589. PubMed ID: 28815772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.